secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001753926-25-000276
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Lipella Pharmaceuticals amends placement agent agreement with Spartan Capital Securities
--------------------------------------------------------------------------------

- Second Amendment removes at-the-market facility restrictions and modifies tail provision to require 10% fee on investments from accredited retail investors within one year of termination.
- Mirror Offering capacity increased to $7,200,000 (including $1,200,000 over-allotment) with registration statements due within 30 days of closings.
- Variable Rate Transaction restrictions reduced to 90 days post-termination or 10 business days after Registration Statement effective date if $6,000,000 of shares sold.
- Company restricted from disposing securities for 90 days after third closing if all shares under that closing are not registered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392625000276/0001753926-25-000276-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392625000276/g084711_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-000276

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer